Advertisement
Of the estimated 7.4 crore (7,40,57,000) population in the 15-18 age bracket, over 3.45 crore have received the first dose of Covaxin so far and their second dose is due in 28 days, he said. ”Adolescents in this age group have been actively participating in the inoculation process, and going by this pace of vaccination, the rest of the beneficiaries in the 15-18 age group are likely to be covered with the first dose by January-end and subsequently their second dose is expected to be done by February-end,” said the Chairman of the Covid working group of the National Technical Advisory Group on Immunisation (NTAGI). Once the 15-18 age group is covered, he said, the government is likely to take a policy decision for initiating the vaccination drive for the 12-14 age group in March, he said.
According to him, there is an estimated 7.5 crore population in the 12-14 age group.
Provisional vaccination reports till 7 am on Monday showed that with more than 39 lakh doses being administered in a span of 24 hours, the cumulative number has exceeded 157.20 crore doses. According to government data, over 3.45 crore first doses have been given to children in the 15-18 years age group so far.
Related Articles
Advertisement
The next phase of COVID-19 vaccination commenced from March 1 last year for people over 60 years of age and those aged 45 and above with specified co-morbid conditions.
The country launched vaccination for all people aged more than 45 years from April 1, 2021.
The government then decided to expand its vaccination drive by allowing everyone above 18 to be vaccinated from May 1. The next phase of COVID-19 vaccination has commenced from January 3 this year for adolescents in the age group of 15-18 years. India began administering the “precaution dose” — a third jab of COVID-19 vaccine — to healthcare, frontline workers including personnel deployed for election duty and those aged 60 and above with comorbidities from January 10 amid the country witnessing a spike in coronavirus infections, driven mainly by the Omicron variant of the virus.